Probe identical duplicate membranes with patient serum and then detect separately with isotype-specific labeled secondary antibodies (e.g., anti-human IgG-HRP on membrane A, anti-human IgM-HRP on membrane B, anti-human IgA-HRP on membrane C), including secondary-only controls for each membrane to monitor non-specific binding; this allows isotype-specific mapping without cross-reactivity between secondaries.